Drug Trial Radar · NCT07448155
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of INCA033989 Following Subcutaneous or Intravenous Administration in Healthy Adult Participants
Last checked: Nov 19, 2026Latest source record: Oct 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
108
Actual
Start
Mar 19, 2026
Primary completion
Nov 14, 2026
Study completion Nov 14, 2026
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- Mar 4, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is being conducted to evaluate the pharmacokinetics, safety, and tolerability of INCA033989 following subcutaneous (SC) or intravenous administration (IV) n healthy adult participants.
Conditions
- Healthy Participants
Interventions
INCA033989Drug
INCA033989 will be administered at protocol defined dose.
Bioavailability enhancerDrug
A bioavailability enhancer will be administered with INCA033989 at protocol defined dose.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pharmacokinetics Parameter: Cmax of INCA33989 following a single SC administration compared with a single IV infusionTime frame: Up to 12 weeks
- Pharmacokinetics Parameter: AUClast of INCA33989 following a single SC administration compared with a single IV infusionTime frame: Up to 12 weeks
- Pharmacokinetics Parameter: AUC0∞ of INCA33989 following a single SC administration compared with a single IV infusionTime frame: Up to 12 weeks
- Number of participants with Treatment-emergent Adverse Events (TEAEs)Time frame: Up to 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Celerion Clinical Research Unit
Tempe, Arizona
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.